Dernières nouvelles et communiqués de presse 


ACR Classifies Gadopiclenol as a Group II Agent

Gadopiclenol solution for injection and Gadopiclenol Pharmacy Bulk Package are available for use in the U.S. following the market launch in February 2023.

Read full article
Bracco Marchio Storico Italiano

Bracco è Marchio Storico di Interesse Nazionale

L’azienda, nata nel 1927 e oggi leader globale nella diagnostica per immagini, entra a far parte dell’esclusivo gruppo di imprese storiche che rappresentano la punta di diamante del Made in Italy.

Read full article
Bracco in Japan

Bracco announces the birth of Bracco Japan Ltd

Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.

Read full article
Bracco’s VUEWAY now in hospitals

Bracco’s VUEWAY™ (gadopiclenol) injection now in hospitals

Preeminent Hospitals and Medical Practices Nationwide Lead in Patient Care with First Use of Bracco’s VUEWAY™ (gadopiclenol) solution for injection for MRI.

Read full article
Green forest

The Impact of Seeing the Full Picture:

Bracco’s standpoint on sustainability - and environmental sustainability in particular - is that it is essential to look at the full picture.

Read full article

Efficacy and Safety of Gadopiclenol

The results of the multicenter, multinational PICTURE clinical trial demonstrate that 0.05 mmol/kg gadopiclenol provides similar morphologic information about CNS lesions and greater contrast enhancement compared with 0.1 mmol/kg gadobutrol.

Read full article
Bracco joins the United Nations Global Compact

Bracco joins the UN Global Compact

The UN Global Compact is a call to companies everywhere to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption.

Read full article

Join us celebrating our new website

We are thrilled to open the doors of our “digital house” created by our people and inhabited by our stories

Read full article
Alberto Spinazzi interview

Drivers and barriers: Innovation in healthcare

Alberto Spinazzi, Bracco Chief Medical and Regulatory Officer, answers some of these questions by illustrating future trends and the importance of prevention for human health.

Read full article
Bracco’s “The Beauty of Imaging” lands back from Expo Dubai  at STEP FuturAbility District, Milan

Bracco’s “The Beauty of Imaging”

The multimedia installation explaining the importance of diagnostic imaging is now on display at STEP, to relate the future of radiology and precision medicine

Read full article
sustainability podcast

Talking Images podcast: The sustainable way – voices of action

Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?

Read full article
Vueway Gadopiclenol

FDA approves Gadopiclenol injection for the U.S. market

Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.

Read full article
BIPSO production site

BIPSO further strengthens environmental protection

BIPSO sets the course for sterile contrast media production according to the latest environmental standards.

Read full article
bracco historical archive

Bracco’s digital historical archive goes online

The astounding Bracco story unfolds across archives that have been thematically divided into five sections: Family, Company, Innovation, Sustainability, and Culture.

Read full article
Vueway Gadopiclenol: another milestone achieved

Gadopiclenol: another milestone achieved

Bracco Imaging and Guerbet have a worldwide collaboration on Gadopiclenol, an investigational macrocyclic gadolinium-based contrast agent (GBCA).

Read full article

The Bracco Fellowships are back

95 grants to celebrate Bracco’s 95th Anniversary

Read full article
US shortage article

The US shortage crisis: Bracco Imaging’s CEO statement on New York Times

The US shortage crisis: Bracco Imaging’s CEO statement on New York Times

Read full article

Cathena has ended: a customised nanomedicine project

A new customised nanomedicine project to fight cancer, a new therapy that includes pre-treating

Read full article
ukrainian flag

First Ukrainian family is welcomed in housing provided by Bracco near the Cesano plant

They have left the war in Ukraine behind and have been welcomed in Italy by the Bracco Group in collaboration with the Town of Cesano and the local community.

Read full article
Bracco Foundation meets Shaharzad Akbar

Bracco Foundation meets Shaharzad Akbar, not to forget the Afghan women

Shaharzad Akbar arrived from Rome where she had provided testimony during a meeting of Italy’s Chamber of Deputies and Senate Joint Committee on Foreign Affairs.

Read full article
gender equality

The world cannot grow without gender equality

Some of the goals in a Policy Paper drafted by the B20 Special Initiative on Women’s Empowerment.

Read full article
Diana Bracco and Gianvito Vilé

Diana Bracco and Gianvito Vilé, winner of the Felder Award, appear at Trieste Next Festival

Trieste Next Festival: Diana Bracco and Gianvito Vilé talk about scientific research and the brain drain.

Read full article
Bracco Foundation

The Bracco Foundation: ten years in the name of culture, science and social engagement

The Bracco Foundation: ten years in the name of culture, science and social engagement.

Read full article

Dossier de presse 

Relations presse : 

Si vous êtes journaliste et que vous avez besoin de plus d’informations sur le Groupe Bracco.


Groupe Bracco 
Relations avec les médias 
Téléphone: +39 (02) 21772279 
Courriel: [email protected]


Bracco Imaging S.p.A 

Relations avec les médias 

Via Caduti di Marcinelle, 13, 20134 - Milan, Italie 

Communiquer avec nous

Veuillez remplir le formulaire ci-dessous et nous communiquerons avec vous

* J'ai lu l'avis de confidentialité des professionnels de BraccoHealthCare et j'accepte le traitement de mes données personnelles permettant à Bracco Imaging SpA (contrôleur de données) de mener ses activités commerciales ou scientifiques et de me contacter avec des communications promotionnelles par courriel, SMS et d'autres canaux numériques et hors ligne, tels que les applications mobiles et les médias sociaux.

Différents pays peuvent avoir mis en place des processus spécifiques pour traiter les signalements d’effets indésirables. Pour signaler un effet indésirable lié aux produits Bracco, vous pouvez trouver des contacts spécifiques et des informations en sélectionnant la page "Pharmacovigilance" de votre pays.